A new approach to an AIDS vaccine: creating antibodies to HIV vif will enable apobec3G to turn HIV-infection into a benign problem
-
Published:2005-01
Issue:2
Volume:64
Page:261-263
-
ISSN:0306-9877
-
Container-title:Medical Hypotheses
-
language:en
-
Short-container-title:Medical Hypotheses
Author:
Jeffrey Fessel W.
Reference22 articles.
1. Prospects for an AIDS vaccine;Desrosiers;Nat Med,2004
2. Hypermutation of HIV-1 DNA in the absence of the vif protein;Lecossier;Science,2003
3. Broad antiretroviral defense by human apobec3G through lethal editing of nascent reverse transcripts;Mangeat;Nature,2003
4. Induction of apobec3G ubiquitination and degradation by an HIV-1 vif-cul5-SCF complex;Yu;Science,2003
5. Mehle A, Strack B, Ancuta P, Gabuzda D. HIV-1 Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin–proteosome pathway. In: 11th conference on retroviruses and opportunistic infections, February 8–11, San Francisco, CA; 2004 [Abstract 62]
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献